NF1 and tuberous sclerosis: Since these tumors tend to grow and become symptomatic mainly in the pediatric age, the dilemma of how to diagnose and when to treat these patients mostly affects pediatric oncologists, pediatric neurologists, and pediatric neurosurgeons; to a lesser extent, this dilemma also affects clinicians dealing with adult NF-1 or TSC patients [27].